Bayer Healthcare Pharmaceuticals - SWOT, Strategy and Corporate Finance Report
Published: December 2012 · Publisher: MarketLine
Bayer Healthcare Pharmaceuticals - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, etc.
- Description
- Table of Contents
- Ask a Question
Bayer Healthcare Pharmaceuticals - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, detailed financials, and corporate actions, providing a 360° view of the company.
Features:
- Detailed information on Bayer Healthcare Pharmaceuticals required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Bayer Healthcare Pharmaceuticals in the form of a SWOT analysis
- An in-depth view of the business model of Bayer Healthcare Pharmaceuticals including a breakdown and examination of key business segments
- Five-year financial information and charts, including balance sheet, income statement, cash flows, market capitalization and multiples, and key ratios for Bayer Healthcare Pharmaceuticals
- Intelligence on Bayer Healthcare Pharmaceuticalsnv’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Bayer Healthcare Pharmaceuticals, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Highlights:
Bayer HealthCare Pharmaceuticals (Bayer Pharma or ‘the company’), a business division of Bayer, primarily focuses on the development and commercialization of drugs in cardiovascular and blood diseases; oncology; ophthalmology; and women's healthcare. It has presence in Europe, the Americas, Asia Pacific, Africa and Middle East. The company is headquartered in Berlin, Germany and employed about 37,000 people as on December 31, 2011. The company recorded revenues of E9,949 million ($13,853.2 million*) during the financial year ended December 2011 (FY2011), a decrease of 0.1% compared with FY2010. The operating profit of the company was E1,897 million ($2,641.4 million*) during FY2011, as compared to an operating profit of E872 million ($1,214.2 million*) in FY2010. *Calculated using a constant conversion rate of E1 = $1.3924 for the financial year ended December 31, 2011.
Reasons to Purchase:
- Gain understanding of Bayer Healthcare Pharmaceuticals and the factors that influence its strategies
- Track strategic initiatives of the company and latest corporate news and actions
- Assess Bayer Healthcare Pharmaceuticals as a prospective partner, vendor or supplier
- Support sales activities by understanding your customers' businesses better
- Stay up to date on Bayer Healthcare Pharmaceuticals’s business structure, strategy and prospects
Features:
- Detailed information on Bayer Healthcare Pharmaceuticals required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Bayer Healthcare Pharmaceuticals in the form of a SWOT analysis
- An in-depth view of the business model of Bayer Healthcare Pharmaceuticals including a breakdown and examination of key business segments
- Five-year financial information and charts, including balance sheet, income statement, cash flows, market capitalization and multiples, and key ratios for Bayer Healthcare Pharmaceuticals
- Intelligence on Bayer Healthcare Pharmaceuticalsnv’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Bayer Healthcare Pharmaceuticals, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Highlights:
Bayer HealthCare Pharmaceuticals (Bayer Pharma or ‘the company’), a business division of Bayer, primarily focuses on the development and commercialization of drugs in cardiovascular and blood diseases; oncology; ophthalmology; and women's healthcare. It has presence in Europe, the Americas, Asia Pacific, Africa and Middle East. The company is headquartered in Berlin, Germany and employed about 37,000 people as on December 31, 2011. The company recorded revenues of E9,949 million ($13,853.2 million*) during the financial year ended December 2011 (FY2011), a decrease of 0.1% compared with FY2010. The operating profit of the company was E1,897 million ($2,641.4 million*) during FY2011, as compared to an operating profit of E872 million ($1,214.2 million*) in FY2010. *Calculated using a constant conversion rate of E1 = $1.3924 for the financial year ended December 31, 2011.
Reasons to Purchase:
- Gain understanding of Bayer Healthcare Pharmaceuticals and the factors that influence its strategies
- Track strategic initiatives of the company and latest corporate news and actions
- Assess Bayer Healthcare Pharmaceuticals as a prospective partner, vendor or supplier
- Support sales activities by understanding your customers' businesses better
- Stay up to date on Bayer Healthcare Pharmaceuticals’s business structure, strategy and prospects
Copyright © FriedlNet. You may share using our tools Please don't cut content from FriedlNet and redistribute by email or post to the web.
Company Snapshot
Bayer Healthcare Pharmaceuticals: Company Overview
Bayer Healthcare Pharmaceuticals: Overview and Key Facts
Bayer Healthcare Pharmaceuticals: Overview
Bayer Healthcare Pharmaceuticals: Key Facts
Bayer Healthcare Pharmaceuticals: Key Employee Biographies
Bayer Healthcare Pharmaceuticals: Major Products and Services
Bayer Healthcare Pharmaceuticals: Company History
Bayer Healthcare Pharmaceuticals: Management Statement
Bayer Healthcare Pharmaceuticals: Locations and Subsidiaries
Bayer Healthcare Pharmaceuticals: Key Competitors
Bayer Healthcare Pharmaceuticals: Company Analysis
Bayer Healthcare Pharmaceuticals: Business Description
Bayer Healthcare Pharmaceuticals: SWOT Analysis
Bayer Healthcare Pharmaceuticals: SWOT Overview
Bayer Healthcare Pharmaceuticals: Strengths
Bayer Healthcare Pharmaceuticals: Weaknesses
Bayer Healthcare Pharmaceuticals: Opportunities
Bayer Healthcare Pharmaceuticals: Threats
Bayer Healthcare Pharmaceuticals: Corporate Financial Deals Activity
Bayer Healthcare Pharmaceuticals: Financial Deals Overview
Bayer Healthcare Pharmaceuticals: Targets and Partners
Bayer Healthcare Pharmaceuticals: Top Deals 2009 - 2013YTD*
Bayer Healthcare Pharmaceuticals: Advisors
Bayer Healthcare Pharmaceuticals: Top Legal Advisors
Bayer Healthcare Pharmaceuticals: Mergers and Acquisitions
Bayer Healthcare Pharmaceuticals: Partnership
Bayer Healthcare Pharmaceuticals: Recent Developments
Bayer Healthcare Pharmaceuticals: News and Events Summary
Bayer Healthcare Pharmaceuticals: Contracts
Bayer Healthcare Pharmaceuticals: Regulatory and Legal Events
Bayer Healthcare Pharmaceuticals: Research & Development
Appendix
Contact Us
Methodology
Definitions
List of Tables
Table 1: Bayer Healthcare Pharmaceuticals: Key Facts
Table 3: Bayer Healthcare Pharmaceuticals: Key Competitors
Table 4: Bayer Healthcare Pharmaceuticals: Deal Activity by Deal Type - Volume (TTM*)
Table 5: Bayer Healthcare Pharmaceuticals: Deal Activity by Deal Type - Volume (2009 - YTD*2013)
Table 6: Bayer Healthcare Pharmaceuticals: Targets and Partners
Table 7: Bayer Healthcare Pharmaceuticals: Top Deals 2009 - 2013YTD*
Table 8: Bayer Healthcare Pharmaceuticals: Legal Advisor Ranking by Value (US$m)
Table 9: Bayer Healthcare Pharmaceuticals: M&A Volume and Value Trend (2009 - YTD*2013)
Table 10: Bayer Healthcare Pharmaceuticals: M&A Activity by Geography (2009 - YTD*2013)
Table 11: Bayer Healthcare Pharmaceuticals: Partnership Volume and Value Trend (2009 - YTD*2013)
Table 12: Bayer Healthcare Pharmaceuticals: Partnership Trend by Deal Type (2009 - YTD*2013)
Table 13: Bayer Healthcare Pharmaceuticals: News and Events Summary
Table 14: Bayer Healthcare Pharmaceuticals: Contracts
Table 15: Bayer Healthcare Pharmaceuticals: Regulatory and Legal Events
Table 16: Bayer Healthcare Pharmaceuticals: Research & Development
List of Figures
Figure 1: Bayer Healthcare Pharmaceuticals: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Bayer Healthcare Pharmaceuticals: Deal Activity by Deal Type - Volume (2009 - YTD*2013)
Figure 3: Bayer Healthcare Pharmaceuticals: M&A Volume and Value Trend (2009 - YTD*2013)
Figure 4: Bayer Healthcare Pharmaceuticals: M&A Activity by Geography (2009 - YTD*2013)
Figure 5: Bayer Healthcare Pharmaceuticals: Partnership Volume and Value Trend (2009 - YTD*2013)
Figure 6: Bayer Healthcare Pharmaceuticals: Partnership Trend by Deal Type (2009 - YTD*2013)
Bayer Healthcare Pharmaceuticals: Company Overview
Bayer Healthcare Pharmaceuticals: Overview and Key Facts
Bayer Healthcare Pharmaceuticals: Overview
Bayer Healthcare Pharmaceuticals: Key Facts
Bayer Healthcare Pharmaceuticals: Key Employee Biographies
Bayer Healthcare Pharmaceuticals: Major Products and Services
Bayer Healthcare Pharmaceuticals: Company History
Bayer Healthcare Pharmaceuticals: Management Statement
Bayer Healthcare Pharmaceuticals: Locations and Subsidiaries
Bayer Healthcare Pharmaceuticals: Key Competitors
Bayer Healthcare Pharmaceuticals: Company Analysis
Bayer Healthcare Pharmaceuticals: Business Description
Bayer Healthcare Pharmaceuticals: SWOT Analysis
Bayer Healthcare Pharmaceuticals: SWOT Overview
Bayer Healthcare Pharmaceuticals: Strengths
Bayer Healthcare Pharmaceuticals: Weaknesses
Bayer Healthcare Pharmaceuticals: Opportunities
Bayer Healthcare Pharmaceuticals: Threats
Bayer Healthcare Pharmaceuticals: Corporate Financial Deals Activity
Bayer Healthcare Pharmaceuticals: Financial Deals Overview
Bayer Healthcare Pharmaceuticals: Targets and Partners
Bayer Healthcare Pharmaceuticals: Top Deals 2009 - 2013YTD*
Bayer Healthcare Pharmaceuticals: Advisors
Bayer Healthcare Pharmaceuticals: Top Legal Advisors
Bayer Healthcare Pharmaceuticals: Mergers and Acquisitions
Bayer Healthcare Pharmaceuticals: Partnership
Bayer Healthcare Pharmaceuticals: Recent Developments
Bayer Healthcare Pharmaceuticals: News and Events Summary
Bayer Healthcare Pharmaceuticals: Contracts
Bayer Healthcare Pharmaceuticals: Regulatory and Legal Events
Bayer Healthcare Pharmaceuticals: Research & Development
Appendix
Contact Us
Methodology
Definitions
List of Tables
Table 1: Bayer Healthcare Pharmaceuticals: Key Facts
Table 3: Bayer Healthcare Pharmaceuticals: Key Competitors
Table 4: Bayer Healthcare Pharmaceuticals: Deal Activity by Deal Type - Volume (TTM*)
Table 5: Bayer Healthcare Pharmaceuticals: Deal Activity by Deal Type - Volume (2009 - YTD*2013)
Table 6: Bayer Healthcare Pharmaceuticals: Targets and Partners
Table 7: Bayer Healthcare Pharmaceuticals: Top Deals 2009 - 2013YTD*
Table 8: Bayer Healthcare Pharmaceuticals: Legal Advisor Ranking by Value (US$m)
Table 9: Bayer Healthcare Pharmaceuticals: M&A Volume and Value Trend (2009 - YTD*2013)
Table 10: Bayer Healthcare Pharmaceuticals: M&A Activity by Geography (2009 - YTD*2013)
Table 11: Bayer Healthcare Pharmaceuticals: Partnership Volume and Value Trend (2009 - YTD*2013)
Table 12: Bayer Healthcare Pharmaceuticals: Partnership Trend by Deal Type (2009 - YTD*2013)
Table 13: Bayer Healthcare Pharmaceuticals: News and Events Summary
Table 14: Bayer Healthcare Pharmaceuticals: Contracts
Table 15: Bayer Healthcare Pharmaceuticals: Regulatory and Legal Events
Table 16: Bayer Healthcare Pharmaceuticals: Research & Development
List of Figures
Figure 1: Bayer Healthcare Pharmaceuticals: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Bayer Healthcare Pharmaceuticals: Deal Activity by Deal Type - Volume (2009 - YTD*2013)
Figure 3: Bayer Healthcare Pharmaceuticals: M&A Volume and Value Trend (2009 - YTD*2013)
Figure 4: Bayer Healthcare Pharmaceuticals: M&A Activity by Geography (2009 - YTD*2013)
Figure 5: Bayer Healthcare Pharmaceuticals: Partnership Volume and Value Trend (2009 - YTD*2013)
Figure 6: Bayer Healthcare Pharmaceuticals: Partnership Trend by Deal Type (2009 - YTD*2013)
Copyright © FriedlNet. You may share using our tools Please don't cut content from FriedlNet and redistribute by email or post to the web.